[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627111":3},{"organization":4,"outcomesModule":7,"designInfo":17,"detailedDescription":16,"studyPopulation":16,"armGroups":23,"interventions":34,"overallOfficials":16,"centralContacts":40,"locations":46,"responsibleParty":58,"collaborators":16,"id":60,"slug":16,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":16,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":67,"minAge":68,"maxAge":16,"enrollmentInfo":69,"targetDuration":16,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":16,"overallStatus":49,"whyStopped":16,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Addpharma Inc.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":16,"otherOutcomes":16},[9,13],{"measure":10,"description":11,"timeFrame":12},"Area under the plasma concentration-time curve during dosing interval (AUCt)","AUCt of AD-116","pre-dose (0hour) to 72hours",{"measure":14,"description":15,"timeFrame":12},"Maximum concentration of drug in plasma (Cmax)","Cmax of AD-116",null,{"allocation":18,"interventionModel":19,"interventionModelDescription":16,"primaryPurpose":20,"observationalModel":16,"timePerspective":16,"maskingInfo":21},"RANDOMIZED","CROSSOVER","TREATMENT",{"masking":22,"maskingDescription":16,"whoMasked":16},"NONE",[24,30],{"label":25,"type":26,"description":27,"interventionNames":28},"Sequence A","EXPERIMENTAL","Period 1 : Reference Drug(Duodart capsule), Period 2 : Test Drug(dutasteride 0.5 mg \u002F tamsulosin 0.4 mg) Single-dose oral administration of AD-1161 (dutasteride 0.5 mg \u002F tamsulosin 0.4 mg) in Period 1, followed by single-dose oral administration of AD-116 (Duodart capsule) in Period 2.",[29],"Drug: AD-116, AD-1161",{"label":31,"type":26,"description":32,"interventionNames":33},"Sequence B","Period 1 : Test Drug(dutasteride 0.5 mg \u002F tamsulosin 0.4 mg), Period 2 : Reference Drug(Duodart capsule) ) Single-dose oral administration of AD-116 (Duodart capsule) in Period 1, followed by single-dose oral administration of AD-1161 (dutasteride 0.5 mg \u002F tamsulosin 0.4 mg) in Period 2.",[29],[35],{"type":36,"name":37,"description":38,"armGroupLabels":39,"otherNames":16},"DRUG","AD-116, AD-1161","Single-dose oral administration of AD-116 or AD-1161, according to randomized sequence.",[25,31],[41],{"name":42,"role":43,"phone":44,"phoneExt":16,"email":45},"JaeHun Jung","CONTACT","+82-31-891-5683","jhjung@addpharma.co.kr",[47],{"facility":48,"status":49,"city":50,"state":16,"zip":16,"country":51,"countryCode":16,"cosmosGeoPoint":52,"geoPoint":57,"contacts":16},"H PLUS YANGJI HOSPITAL, Seoul","RECRUITING","Seoul","South Korea",{"type":53,"coordinates":54},"Point",[55,56],126.9784,37.566,{"lat":56,"lon":55},{"type":59,"investigatorFullName":16,"investigatorTitle":16,"investigatorAffiliation":16,"oldNameTitle":16,"oldOrganization":16},"SPONSOR","100627111",false,"NCT07444385","A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects","An Open-Label, Randomized, Single-Dose, Two-Sequence, Two-Period Crossover Clinical Trial to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Volunteers Under Fed Conditions","Inclusion Criteria:\n\n* Body weight equal to or greater than 50kg and Body mass index (BMI) between 18.0 kg\u002Fm2 and 30.0 kg\u002Fm2 at the time of screening visit\n* The Age equal to or greater than 19 in healthy adult male volunteers at the time of screening visit\n\nExclusion Criteria:\n\n* Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration\n* Other exclusions applied",true,"MALE","19 Years",{"count":70,"type":71},44,"ESTIMATED","INTERVENTIONAL",[74],"PHASE1","A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 Under Fed Conditions in Healthy Adult Male Subjects",[77],"Benign Prostatic Hyperplasia","2026-03-01",{"date":80,"type":81},"2026-03-03","ACTUAL",{"date":83,"type":81},"2026-02-26",{"date":85,"type":71},"2026-05-08",{"name":5,"class":6},1]